John Tierney, DO
Orthopedic Surgery · Dedham, MANPI 1417913047
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.2%), ownership interests and other — rather than concentrated in one kind of arrangement. Anika Therapeutics, Inc. accounts for 95.9% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2020 at $87,535 and has fallen 97.5% since, to $2,174 in 2025. Among orthopedic surgery clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $1888.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Anika Therapeutics, Inc.$129K
- Kairos Surgical Inc$1K
- Depuy Synthes Products, Inc.$1K
- Smith+Nephew$554
- Arthrex$482
- Pacira Pharmaceuticals Incorporated$379
- plus $2K from 17 others
What the payments were for
- Consulting fees$60,54045%
- Speaking & faculty fees$1,8001%
- Travel & lodging$3,0792%
- Food & beverage$4,1203%
- Ownership interest$57,05643%
- Other$7,4706%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Anika Therapeutics, Inc. | 29 | $128,595 |
| Kairos Surgical Inc | 3 | $1,264 |
| Depuy Synthes Products, Inc. | 1 | $1,000 |
| Smith+Nephew | 4 | $554 |
| Arthrex | 3 | $482 |
| Pacira Pharmaceuticals Incorporated | 5 | $379 |
| Pacira Therapeutics, Inc. | 6 | $248 |
| Heron Therapeutics, Inc. | 3 | $242 |
| Linvatec Corporation | 1 | $185 |
| Osteoremedies, LLC | 1 | $171 |
| Stryker | 2 | $162 |
| Exactech, Inc. | 1 | $151 |
| Arthrosurface Incorporated | 1 | $112 |
| Vericel Corporation | 1 | $109 |
| Bone Support Inc. | 1 | $108 |
| Conformis, Inc. | 1 | $99 |
| Acumed LLC | 1 | $83 |
| Bioventus LLC | 2 | $36 |
| Fidia Pharma USA Inc. | 1 | $23 |
| Orthofix Medical, Inc. | 1 | $18 |
| Baudax Bio Inc. | 1 | $15 |
| Pfizer | 1 | $15 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TACTOSET$63,851
- Zilretta$243
- Iovera$229
- Zynrelef$221
- BioBrace 23mm$185
- BIOWASH Surgical Irrigation$171
- OsteoBoost Select 5cc$171
- Remedy Spacer$171
- BioBrush$171
- Regeneten$165
- EQUINOXE$151
- N/A$137
- INSPACE$128
- Integrity$120
- IOVERA SYSTEM$117
- MACI$109
- CERAMENTBONE VOID FILLER$108
- LENS Surgical Imaging System$105
- Coblation Wands$105
How this compares
$134,063 in reported general payments places this provider in the 95th percentile of 42 orthopedic surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 18 | $200 |
| Oxycodone Hcl | 30 | $92 |
| Amoxicillin | 12 | $54 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Dedham
- Avi GruninDedham$0
- Amgad AminBoston$195K
- Zachary BerlinerBoston$14K
- Melissa GrossBoston$13K
- Ivan GolubBoston$7K
- Paul HarasimowiczAyer$4K
- Barry BickleyHaverhill$3K
- Paul PongorMarlboro$2K
- Donald O'MalleyFalmouth$1K
- Markian StecykMarlboro$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.